MYC and neoplasm: In turn, Wu and colleagues (2014) confirmed the tumor growth inhibition after RSV intravesical treatment due to STAT3 signaling pathway inhibition (reduced expression of survivin, cyclin D1, c-Myc and VEGF) [80].